Coronary calcium screening in asymptomatic individuals is associated with progressively higher downstream noninvasive testing, invasive angiography, and medical costs as CAC scores increase (p<0.001).
Cohort
valor p: p=<0.001
OBJECTIVES: We prospectively evaluated procedural costs and resource consumption patterns in the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) study after coronary calcium (CAC) measurements. BACKGROUND: Controversy surrounds expansion of cardiovascular disease (CVD) screening to include atherosclerosis imaging as the result of concern whether induced costs will outweigh any benefit. METHODS: Detailed risk factor and CAC measurements with 4-year follow-up for CVD death or myocardial infarction and procedures were performed. Costs were estimated with the use of Medicare reimbursement rates (discounted and inflation corrected). Cox survival analysis was used to estimate procedures and events. RESULTS: CAC scores varied widely but were skewed toward low scores with 56.7% of screened subjects having CAC scoresor=400. Noninvasive testing was infrequent and medical costs were low among subjects with low CAC scores, both rising progressively with increasing CAC scores (por=1,000. Similarly, invasive coronary angiography rose progressively with increasing scores (por=1,000. CONCLUSIONS: CAC scanning is associated with a marked differential in downstream frequency of medical tests and costs, ranging from a very low frequency of testing and invasive procedures among a predominantly large percentage of subjects with low CAC scores, to selectively concentrated testing and procedures among a small number of subjects with CAC scores>400. Thus, CAC scanning appears to foster efficient selective testing patterns among asymptomatic individuals at risk for CVD.
Shaw et al. (Tue,) conducted a cohort in Asymptomatic individuals at risk for cardiovascular disease. Coronary calcium (CAC) screening was evaluated on Procedural costs and resource consumption patterns (noninvasive testing and invasive coronary angiography) (p=<0.001). Coronary calcium screening in asymptomatic individuals is associated with progressively higher downstream noninvasive testing, invasive angiography, and medical costs as CAC scores increase (p<0.001).